AI Science Tracker
EN

CatBoost evaluates fragility-fracture risk in a community cohort

Seoul National University College of Medicine · 10 Feb 2020 · medicine

Discovery

CatBoost evaluates fragility-fracture risk in a community cohort

Source check: Source checked. Not independent scientific confirmation.

Finding: CatBoost evaluated fragility-fracture risk in 2,227 participants from the Korean Ansung cohort followed for a mean 7.5 years. Reported total-fracture AUC was 0.688, compared with 0.663 for FRAX, using repeated internal cross-validation. The study also ranked candidate predictors, but did not estimate time to fracture or demonstrate benefit from model-guided prevention. External populations remain to be tested.

Technology: CatBoost

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Categorical gradient boosting learns fracture-risk relationships from clinical variables and is compared with FRAX, SVM and logistic regression.
Test and result
Retrospective outcome modeling within a longitudinal cohort, with three-fold cross-validation repeated 1,000 times.
Limitation / still unknown
External ethnic/population validation, time-to-event prediction and clinical benefit remain unestablished.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7059838/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary full paper relevant model Methods, study Results and limitations; exact primary front-matter identity and Europe PMC metadata checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.